# Integrated Commercialization Solutions LLC – FDA Inspection, Sep 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-llc/c3846706-ef92-4223-9778-3cef56a0a512
Source feed: FDA_Inspections

> FDA inspection 1068353 of Integrated Commercialization Solutions LLC, September 13, 2018. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068353
- Company Name: Integrated Commercialization Solutions LLC
- Inspection Date: 2018-09-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1270094 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/integrated-commercialization-solutions-llc/4ac5be64-592c-44be-9521-1cceacae6f65)

## Related Officers

- [Andrew J. Barrowcliff](https://www.keypedia.com/people/andrew-j-barrowcliff/5dd49407-9028-4c84-9e86-3f0b6239538e)
- [FDA Associated Person](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.keypedia.com/companies/integrated-commercialization-solutions-llc/d1ff0552-0b6b-4a8d-bbf0-8725d6b0641c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c